You're doing most of the work, but I'll be happy to tag along (on your lab coattail).Polly wrote:OK, shall we become lab partners and try to develop anti-ligand treatments? Of course, they wouldn't work for long, because the bacteria would soon develop new ones. Devious little critters, ain't they?
This observation (from the article you cited) appears to be key in understanding what's going on with vitamin D, VDRs, and the ability of bacteria to suppress the innate immune system. But note that this suppression of the innate immune system apparently happens strictly on a local basis, where the rubber meets the road — not within the heart of the immune system itself, but out on the firing line, at one of the immune system's most critical sentry points. I'm guessing that's why it's generally overlooked by most mainstream researchers who are investigating autoimmune-type syndromes. They're thinking traditionally, and looking for markers of the suppression of the immune system in conventional (big picture) terms, and it never occurs to them to view it as a strictly local event.
The red emphasis is mine, of course. And the remark about the 2 different forms of vitamin D also clearly illustrates why doctors who choose to test for 1,25(OH)D, rather than 25(OH)D are missing the most important point about the entire process — the higher one's 1,25(OH)D level, the worse the threat of autoimmune development, because when that test result is elevated, it indicates that VDRs have been inactivated by rogue ligands, rather than activated by vitamin D {in the 1,25(OH)D form}.However, bacteria create ligands, which like 25-D, inactivate the VDR and, in turn, the innate immune response. This allows the microbes to proliferate. In response, the body increases production of 1,25-D from 25-D, leading to one of the hallmarks of chronic inflammatory disease: a low 25-D and a high 1,25-D.
This pattern is a result of the disease process rather than a cause. For a variety of reasons, neither increased consumption of vitamin D nor the body's synthesis of additional 1,25-D is ultimately effective at combatting infection. However, bacteria create ligands, which like 25-D, inactivate the VDR and, in turn, the innate immune response. This allows the microbes to proliferate. In response, the body increases production of 1,25-D from 25-D, leading to one of the hallmarks of chronic inflammatory disease: a low 25-D and a high 1,25-D.
This pattern is a result of the disease process rather than a cause. For a variety of reasons, neither increased consumption of vitamin D nor the body's synthesis of additional 1,25-D is ultimately effective at combatting infection.
And by the same token (and even more importantly), I'm going to postulate that when the 25(OH)D test result is low, that also implies that available VDRs have been depleted, and as a result, autoimmune disease may be imminent, unless drastic intervention is taken.
IOW, my point here is that the 25(OH)D test result doesn't just tell us what our blood vitamin D level might be — much more than that, it warns us when our VDR availability may be approaching a dangerously low level.
Love,
Tex
P. S. I'm bearing down on those tax forms now, and the end is in sight (I hope). LOL.